ANIK Q4 2018 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$208M

Q4 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$27M-8.3% YoY

Gross Profit

$20M74.0% margin

Operating Income

$10M36.2% margin

Net Income

$8M28.6% margin

EPS (Diluted)

$0.54

QoQ Revenue Growth

+0.6%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$10M

Stock-Based Comp.

$982,000

Balance Sheet

Total Assets

$279M

Total Liabilities

$15M

Stockholders' Equity

$264M

Cash & Equivalents

$89M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$29M	-8.3%
Gross Profit	$20M	$21M	-3.5%
Operating Income	$10M	$10M	+0.3%
Net Income	$8M	$8M	-4.3%

Revenue Segments

Product

$27M100%